Miriam Martini

8.4k total citations · 3 hit papers
45 papers, 4.5k citations indexed

About

Miriam Martini is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Miriam Martini has authored 45 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Miriam Martini's work include PI3K/AKT/mTOR signaling in cancer (15 papers), Colorectal Cancer Treatments and Studies (9 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Miriam Martini is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (15 papers), Colorectal Cancer Treatments and Studies (9 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Miriam Martini collaborates with scholars based in Italy, Switzerland and United States. Miriam Martini's co-authors include Emilio Hirsch, Federico Gulluni, Maria Chiara De Santis, Alberto Bardelli, Salvatore Siena, Federica Di Nicolantonio, Laura Braccini, Andrea Sartore‐Bianchi, Milo Frattini and Luca Mazzucchelli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Miriam Martini

42 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

2008 1.3k citations Federica Di Nicolantonio, Miriam Martini et al. profile →
PI3K/AKT signaling pathway and cancer: an updated review

2014 912 citations Miriam Martini, Maria Chiara De Santis et al. Annals of Medicine profile →
PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies

2009 601 citations Andrea Sartore‐Bianchi, Miriam Martini et al. Cancer Research profile →

Peers

Miriam Martini

ONCOL

PFM

PRM

T.R. Jeffry Evans United Kingdom

Kuen‐Feng Chen Taiwan

Adrian M. Jubb United Kingdom

Francesco Hofmann Switzerland

Guro E. Lind Norway

Jianping Xiong China

Andrew B. Nixon United States

Diego Arango Spain

Ron Bose United States

David S. Shames United States

T.R. Jeffry Evans United Kingdom

Miriam Martini

1.9k ×0.8

ONCOL

1.8k ×0.9

667 ×0.6

PFM

686 ×0.7

PRM

802 ×0.8

Citations per year, relative to Miriam Martini Miriam Martini (= 1×) peers T.R. Jeffry Evans

Countries citing papers authored by Miriam Martini

Since Specialization

Citations

This map shows the geographic impact of Miriam Martini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Martini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Martini more than expected).

Fields of papers citing papers by Miriam Martini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Martini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Martini. The network helps show where Miriam Martini may publish in the future.

Co-authorship network of co-authors of Miriam Martini

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Martini. A scholar is included among the top collaborators of Miriam Martini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Martini. Miriam Martini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Costamagna, Andrea, et al.. (2025). The molecular logic of early metastasis in pancreatic cancer: crosstalk between tumor and microenvironment. Frontiers in Cell and Developmental Biology. 13. 1726581–1726581.

Santis, Maria Chiara De, Bruno Bockorny, Emilio Hirsch, Paola Cappello, & Miriam Martini. (2024). Exploiting pancreatic cancer metabolism: challenges and opportunities. Trends in Molecular Medicine. 30(6). 592–604. 31 indexed citations

Barutta, Federica, Stefania Bellini, Shunsuke Kimura, et al.. (2022). Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy. Autophagy. 19(2). 505–524. 67 indexed citations

Costamagna, Andrea, et al.. (2021). Cholesterol Activates Cyclic AMP Signaling in Metaplastic Acinar Cells. Metabolites. 11(3). 141–141. 4 indexed citations

Costamagna, Andrea, Paola Cappello, Francesco Novelli, et al.. (2021). Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis. Gastroenterology. 162(4). 1242–1255.e11. 4 indexed citations

Petrillo, Sara, Giovanna Carrà, Paolo Bottino, et al.. (2020). A Novel Multiplex qRT-PCR Assay to Detect SARS-CoV-2 Infection: High Sensitivity and Increased Testing Capacity. Microorganisms. 8(7). 1064–1064. 37 indexed citations

Santis, Maria Chiara De, Federico Gulluni, Carlo Cosimo Campa, Miriam Martini, & Emilio Hirsch. (2019). Targeting PI3K signaling in cancer: Challenges and advances. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1871(2). 361–366. 80 indexed citations

Martini, Miriam, Maria Chiara De Santis, & Emilio Hirsch. (2017). The turtle and the rabbit story in a modern (PI3)key. Molecular & Cellular Oncology. 5(1). e1405141–e1405141. 1 indexed citations

Gulluni, Federico, Miriam Martini, & Emilio Hirsch. (2017). Cytokinetic Abscission: Phosphoinositides and ESCRTs Direct the Final Cut. Journal of Cellular Biochemistry. 118(11). 3561–3568. 10 indexed citations

10.

Campa, Carlo Cosimo, Miriam Martini, Maria Chiara De Santis, & Emilio Hirsch. (2015). How PI3K-derived lipids control cell division. Frontiers in Cell and Developmental Biology. 3. 61–61. 12 indexed citations

11.

Martini, Miriam, Maria Chiara De Santis, Laura Braccini, Federico Gulluni, & Emilio Hirsch. (2014). PI3K/AKT signaling pathway and cancer: an updated review. Annals of Medicine. 46(6). 372–383. 912 indexed citations breakdown →

12.

Franco, Irene, Federico Gulluni, Carlo Cosimo Campa, et al.. (2014). PI3K Class II α Controls Spatially Restricted Endosomal PtdIns3P and Rab11 Activation to Promote Primary Cilium Function. Developmental Cell. 28(6). 647–658. 158 indexed citations

13.

Zecchin, Davide, Valentina Boscaro, Enzo Médico, et al.. (2013). BRAF V600E Is a Determinant of Sensitivity to Proteasome Inhibitors. Molecular Cancer Therapeutics. 12(12). 2950–2961. 16 indexed citations

14.

Martini, Miriam, Mariangela Russo, Simona Lamba, et al.. (2013). Mixed Lineage Kinase MLK4 Is Activated in Colorectal Cancers Where It Synergistically Cooperates with Activated RAS Signaling in Driving Tumorigenesis. Cancer Research. 73(6). 1912–1921. 16 indexed citations

15.

Martini, Miriam, Elisa Ciraolo, Federico Gulluni, & Emilio Hirsch. (2013). Targeting PI3K in Cancer: Any Good News?. Frontiers in Oncology. 3. 108–108. 82 indexed citations

16.

Braccini, Laura, Elisa Ciraolo, Miriam Martini, et al.. (2012). PI3K keeps the balance between metabolism and cancer. Advances in Biological Regulation. 52(3). 389–405. 38 indexed citations

17.

Martini, Miriam, Loredana Vecchione, Salvatore Siena, Sabine Tejpar, & Alberto Bardelli. (2011). Targeted therapies: how personal should we go?. Nature Reviews Clinical Oncology. 9(2). 87–97. 90 indexed citations

18.

Sartore‐Bianchi, Andrea, Katia Bencardino, Federica Di Nicolantonio, et al.. (2010). Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer. Targeted Oncology. 5(1). 19–28. 25 indexed citations

19.

Sartore‐Bianchi, Andrea, Miriam Martini, Francesca Molinari, et al.. (2009). PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies. Cancer Research. 69(5). 1851–1857. 601 indexed citations breakdown →

20.

Arena, Sabrina, Claudio Isella, Miriam Martini, et al.. (2007). Knock-in of Oncogenic Kras Does Not Transform Mouse Somatic Cells But Triggers a Transcriptional Response that Classifies Human Cancers. Cancer Research. 67(18). 8468–8476. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact